1-methyl-3-isobutylxanthine and azelastine

1-methyl-3-isobutylxanthine has been researched along with azelastine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Bachelet, M; Hatmi, M; Havet, N; Vargaftig, BB	1

Other Studies

2 other study(ies) available for 1-methyl-3-isobutylxanthine and azelastine

Article	Year
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
Azelastine potentiates the prostaglandin-induced increase of cyclic AMP content in human platelets and in guinea-pig alveolar macrophages. Prostaglandins, 1992, Volume: 43, Issue:5 Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Blood Platelets; Cell Survival; Cyclic AMP; Dinoprostone; Drug Synergism; Epoprostenol; Guinea Pigs; Humans; In Vitro Techniques; Macrophages, Alveolar; Phthalazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins; Theophylline	1992

Article

Year

Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.

Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10

Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers

2012

Azelastine potentiates the prostaglandin-induced increase of cyclic AMP content in human platelets and in guinea-pig alveolar macrophages.

Prostaglandins, 1992, Volume: 43, Issue:5

Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Blood Platelets; Cell Survival; Cyclic AMP; Dinoprostone; Drug Synergism; Epoprostenol; Guinea Pigs; Humans; In Vitro Techniques; Macrophages, Alveolar; Phthalazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins; Theophylline

1992